<DOC>
	<DOCNO>NCT03016949</DOCNO>
	<brief_summary>The study evaluate humoral immunogenicity various schedule combination full dose inactivated polio vaccine ( IPV ) via intramuscular administration ( IM ) fractional dose inactivate poliovaccine ( f-IPV ) via intradermal administration ( ID ) .</brief_summary>
	<brief_title>A Study Evaluate Immunogenicity Various Schedules Inactivated Polio Vaccine</brief_title>
	<detailed_description>The study conduct set IPV use polio prevention infant immunization schedule . The study population include infant Uruguay , pioneer country immunization program Latin America , tOPV ( trivalent oral polio vaccine ) use 2012 , program change all-IPV schedule without transition . The primary IPV immunization schedule country stand-alone vaccine 2 , 4 6 month age , booster dose 15 month . This setting allow evaluation IPV immunogenicity scenario circulation poliovirus highly unlikely . Infants receive two three dos full dose IPV IM fractional dose f-IPV ID , various schedule combination ( 6 14 week ; 10 14 week ; 14 36 week ; 6 , 14 36 week ; 10 , 14 36 week ) . Immunological safety assessment make one dose , two dos three dos . The study conduct Montevideo , Uruguay total 1493 infant randomize 6 group . Other vaccine comprise DTPw-HB-Hib ( pentavalent combine diphtheria-tetanus-whole cell pertussis-hepatitis B-Hib vaccine ) , Pneumococcal conjugate vaccine , Rotavirus administer concomitantly . Optimum immunogenicity expect dose/s IPV post-eradication era balance cost supply constraint IPV . This study critical determine many dos IPV schedule recommend post-eradication era cessation OPV ( oral polio vaccine ) usage globally .</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants 6 week age ( 7 + 7 day ) date first vaccination Healthy , assess medical history physical examination study physician Written inform consent obtain parent legal representative properly inform study able comply plan study procedure Vaccinated poliovirus vaccine prior inclusion A household contact OPV vaccination history past 4 week HIV infection pharmacologic immunosuppression . Known allergy component study vaccine ( phenoxyethanol , formaldehyde ) Uncontrolled coagulopathy blood disorder contraindicate intramuscular intradermal injection . Acute severe febrile illness day vaccination deem Investigator contraindication vaccination . Not suitable inclusion unlikely comply protocol opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>5 Weeks</minimum_age>
	<maximum_age>7 Weeks</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>